Therapeutic Asset Ratings

122 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Crovalimab Sickle Cell Disease	Hoffmann-La Roche	P2	CCC (55)
Clonidine Sickle Cell Disease	Centre Hospitalier Universitaire Saint Pierre	P4	CCC (54)
Anti-Thymoglobulin, Rabbit Sickle Cell Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (54)
Mesna Sickle Cell Disease	Columbia University	P2	CCC (54)
PENTOSTATIN Sickle Cell Disease	City of Hope Medical Center	P2	CCC (54)
Osivelotor Sickle Cell Disease	Pfizer	P2/3	CCC (53)
Iloprost Sickle Cell Disease	University Hospital, Rouen	P3	CCC (52)
LOVOTIBEGLOGENE AUTOTEMCEL Sickle Cell Disease	Genetix Biotherapeutics Inc.	P3	CCC (52)
pcv21 Sickle Cell Disease	Sanofi	P3	CCC (52)
Prevnar 20 Sickle Cell Disease	Sanofi	P3	CCC (52)
Red Blood Cell Sickle Cell Disease	University of Pittsburgh	P3	CCC (52)
Rilzabrutinib Sickle Cell Disease	Sanofi	P3	CCC (52)
Autologous Cd34+ Cells Transduced With Tns9.3.55 Sickle Cell Disease	Daniel Bauer	P2	CCC (52)
Autologous Cd34+ Hsc Cells Transduced With The Lentiviral Vector Containing A Shrna Targeting Bcl11A Sickle Cell Disease	David Williams	P2	CCC (52)
Azathioprine Sickle Cell Disease	St. Jude Children's Research Hospital	P2	CCC (52)
Bortezomib Sickle Cell Disease	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
HEMOPEXIN (PLASMA DERIVED) Sickle Cell Disease	CSL Behring	P2	CCC (52)
Inno-206 Sickle Cell Disease	Memorial Sloan Kettering Cancer Center	P2	CCC (52)
Pociredir Sickle Cell Disease	Fulcrum Therapeutics	P2	CCC (52)
REGADENOSON Sickle Cell Disease	St. Jude Children's Research Hospital	P2	CCC (52)
Tetrahydrouridine Sickle Cell Disease	Novo Nordisk A/S	P2	CCC (52)
TOVINONTRINE Sickle Cell Disease	Cardurion Pharmaceuticals, Inc.	P2	CCC (52)
Defibrotide Sickle Cell Disease	New York Medical College	P2	CCC (51)
Epeleuton Sickle Cell Disease	Afimmune	P2	CCC (51)
Rifaximin Sickle Cell Disease	Bausch Health Americas, Inc.	P2	CCC (51)

Showing 51 to 75 of 122 assets

PreviousPage 3 of 5Next